New immunohistologic findings on the differential role of cyclooxygenase 1 and cyclooxygenase 2 in nasal polyposis

American Journal of Rhinology

Volumn 19, Issue 2, 2005, Pages 111-116

  Gosepath, Jan ^a,b   Brieger, Juergen ^a   Mann, Wolf J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; CAPILLARY PERMEABILITY; CHRONIC SINUSITIS; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NOSE MUCOSA; NOSE POLYP; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RESPIRATORY TRACT MUCOSA; RHINITIS;

EID: 20144365434     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.1177/194589240501900201     Document Type: Article

References (24)

1. Pinto S, Gallo O, Polli G, et al. Cyclooxygenase and lipoxygenase metabolite generation in nasal polyps. Prostaglandins Leukot Essent Fatty Acids 57:533-537, 1997.
2. Eschwege P, de Ledinghen V, Camilli T, et al. Cyclooxygenases. Presse Med 30:511-514, 2001.
3. Demoly P, Crampette L, Lebel B, et al. Expression of cyclooxygenase 1 and 2 proteins in upper respiratory mucosa. Clin Exp Allergy 28:278-283, 1998.
4. Eschwege P, de Ledinghen V, Camilli T, et al. Arachidonic acid and prostaglandins, inflammation, and oncology [in French]. Presse Med 30:508-510, 2001.
5. Bruynzeel PL, Kok PT, Hamelink ML, et al. Exclusive leukotriene C4 synthesis by purified human eosinophils induced by opsonized zymosan. FEBS Lett 189:350-354, 1985.
6. Peters SP, Naclerio RM, Schleimer RP, et al. The pharmacologic control of mediator release from human basophils and mast cells. Respiration 50(suppl 2):116-122, 1986.
7. Picado C, Fernandez-Morata JC, Juan M, et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 160:291-296, 1999.
8. Yun CB, Lee BH, and Jang TJ. Expression of glucocorticoid receptors and cyclooxygenase-2 in nasal polyps from nonallergic patients. Ann Otol Rhinol Laryngol 111:61-67, 2002.
9. Grzegorczyk J, Kowalski ML, Kornatowski T, and Pawliczak R. Expression of cyclooxygenase in nasal polyps from atopic and nonatopic subjects. J Investig Allergol Clin Immunol 9:380-385, 1999.
10. Fernandez-Morata JC, Mullol J, Fuentes M, et al. Regulation of cyclooxygenase-1 and -2 expression in human nasal mucosa. Effects of cytokines and dexamethasone. Clin Exp Allergy 30: 1275-1284, 2000.
11. Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 87:803-809, 1998.
12. Lund VJ, and Kennedy DW. Quantification for staging sinusitis. The staging and therapy group. Ann Otol Rhinol Laryngol Suppl 167:17-21, 1995.
13. Liu CM, Hong CY, Shun CT, et al. Inducible cyclooxygenase and interleukin 6 gene expressions in nasal polyp fibroblasts: Possible implication in the pathogenesis of nasal polyposis. Arch Otolaryngol Head Neck Surg. 128:945-951, 2002.
14. Mullol J, Fernandez-Morata JC, Roca-Ferrer J, et al. Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. J Allergy Clin Immunol 109:824-830, 2002.
15. Sousa A, Pfister R, Christie PE, et al. Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 52: 940-945, 1997.
16. Smith WL, and De Witt DL. Prostaglandin endoperoxidase H synthases-1 and -2. Adv Immunol 62:167-215, 1996.
17. Cowburn AS, Sladek K, Soja J, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 101:834-846, 1998.
18. Seno H, Oshima M, Ishikawa TO, et al. Cyclooxygenase-2 and prostaglandin E (2) receptor EP (2)-dependent angiogenesis in APC (Delta 716) mouse intestinal polyps. Cancer Res 62:506-511, 2002.
19. Kawada M, Seno H, Wada M, et al. Cyclooxygenase-2 expression and angiogenesis in gastric hyperplastic polyp - Association with polyp size. Digestion 67:20-24, 2003.
20. Guo J, Wang X, and Tao G. Expression of vascular endothelial growth factor and transforming growth factor-beta 1 in nasal polyps. Zhonghua Er Bi Yan Hou Ke Za Zhi 36:83-86, 2001.
21. Coste A, Brugel L, Maitre B, et al. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J 15:367-372, 2000.
22. Jiang S, Dong Z, and Yang Z. Expression and the role of vascular endothelial growth factor mRNA in nasal polyps. Lin Chuang Er Bi Yan Hou Ke Za Zhi 15:339-340, 2001.
23. Wittekindt C, Hess A, Bloch W, et al. Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa. Eur Arch Otorhinolaryngol 259:294-298, 2002.
24. Gosepath J, Brieger J, Lehr HA, and Mann WJ. Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps. Am J Rhinol 19:7-13, 2005.